Israel's Teva Pharma appoints Lundbeck's Kare Schultz as CEO

JERUSALEM (Reuters) - Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president on Monday, as it struggles with heavy debts and fierce competition for its generic drugs in the United States.